CBD can cause liver injury, and the risk is real enough that the FDA has flagged it as a safety concern. In a randomized trial of healthy adults taking a moderate dose (about 250 to 550 mg per day) for just four weeks, 5.6% developed liver enzyme elevations more than three times the normal upper limit, compared to 0% in the placebo group. That said, the picture is more nuanced than a simple yes or no. Dose, other medications, and your liver’s baseline health all play a role in how much risk you’re actually taking on.
What CBD Does to Your Liver
Your liver is the organ responsible for breaking down CBD, and it works hard to do so. CBD is processed primarily by two liver enzyme families, CYP3A4 and CYP2C19, which convert it into at least eight different metabolites. This processing also triggers the liver to ramp up production of several enzyme types, essentially forcing the organ to work overtime.
CBD influences at least 50 genes involved in fat and drug metabolism. At higher doses, this metabolic burden can stress liver cells. Research from the FDA’s National Center for Toxicological Research has linked CBD exposure to cell cycle disruption, programmed cell death, and a type of cellular stress called ER stress in liver tissue. These are the mechanisms behind the liver enzyme spikes that show up in blood tests.
What the Clinical Data Shows
The clearest human safety data comes from an FDA-conducted randomized trial. Healthy adults received CBD oral solution at 5 mg/kg per day (split into two doses) for 28 days, with weekly blood draws to monitor liver function. Eight participants, or 5.6%, developed clinically significant liver enzyme elevations. Nobody in the placebo group did. These elevations are a standard marker of liver stress or damage, and they occurred at doses within the labeled range for the only FDA-approved CBD drug.
That approved drug, Epidiolex, is a purified CBD product prescribed for severe seizure disorders at doses up to 25 mg/kg per day. During clinical trials for Epidiolex, the risk of liver enzyme elevation was even more pronounced at those higher doses. The FDA noted that liver injury appeared both in patients taking other liver-affecting medications and in patients who were not, meaning CBD alone was enough to cause it.
For context, a typical over-the-counter CBD product might deliver 25 to 50 mg per day, which is far below the 250 to 550 mg daily dose used in the FDA trial. No rigorous long-term studies have tracked what happens to the liver at these lower consumer doses over months or years. That gap in the data is part of the problem: most people using CBD have no clinical monitoring, so early signs of liver stress could easily go unnoticed.
Drug Interactions Raise the Risk
One of the biggest liver safety concerns with CBD isn’t CBD alone. It’s what happens when CBD meets other medications. CBD is a potent inhibitor of several liver enzymes that break down common drugs. A clinical study found that CBD increased blood levels of omeprazole (a common heartburn medication) by 207%, losartan (a blood pressure drug) by 77%, and midazolam (a sedative) by 56%. It also increased caffeine levels by 39%.
This happens because CBD blocks the same enzyme pathways these drugs rely on for clearance, particularly CYP2C19, CYP2C9, and CYP3A. When those pathways are blocked, other drugs linger in the bloodstream longer and at higher concentrations than intended. The result is a double hit: the liver is simultaneously processing CBD and dealing with unexpectedly high levels of whatever else you’re taking. Anti-seizure medications like clobazam are especially affected, which is why patients on Epidiolex require regular liver monitoring.
If you take any prescription medication that’s processed by the liver, adding CBD creates a meaningful interaction risk. This includes many antidepressants, blood thinners, statins, and anti-seizure drugs.
The Paradox: CBD May Also Protect the Liver
The relationship between CBD and the liver isn’t purely harmful. Preclinical research (mostly in animal and cell models) suggests CBD may have protective effects against certain types of liver damage. Through its interaction with receptors involved in inflammation and fat metabolism, CBD has shown potential to reduce oxidative stress, limit immune cell infiltration into liver tissue, prevent scarring (fibrosis), and support metabolic balance.
These findings are preliminary and have not been confirmed in human clinical trials. But they point to a complex picture where CBD’s effect on the liver depends heavily on the context: dose, duration, existing liver health, and what other substances are in the mix.
Signs of Liver Trouble
Liver enzyme elevations often produce no obvious symptoms, which is why the FDA has expressed concern about unmonitored CBD use. When symptoms do appear, they can include unusual fatigue, loss of appetite, nausea, dark urine, or yellowing of the skin or eyes. In the clinical trials, liver enzyme levels typically improved after CBD was stopped or the dose was reduced.
If you’re using CBD regularly, especially at doses above 50 mg per day or alongside other medications, periodic liver function blood tests are the only reliable way to catch problems early. These are simple, inexpensive blood draws that any primary care provider can order.
What Makes Some People More Vulnerable
Several factors increase the likelihood of liver issues with CBD. Taking higher doses is the most straightforward risk factor, with clinical data showing dose-dependent enzyme elevations. Using CBD alongside medications that compete for the same liver enzymes (particularly CYP2C19 and CYP3A4 pathways) significantly compounds the risk. People with pre-existing liver conditions have reduced capacity to process CBD safely, since the very enzymes required for CBD metabolism may already be compromised.
The unregulated nature of most CBD products adds another layer of uncertainty. Unlike the pharmaceutical-grade CBD used in clinical trials, consumer products vary widely in actual CBD content, purity, and the presence of other compounds. Some products contain more or less CBD than labeled, and some include contaminants that carry their own liver risks. Without FDA oversight of these products, what you’re actually putting into your body may not match what’s on the label.